Learn about the scientists behind the discoveries, entrepreneurs,
political leaders, and significant events, people and institutions that are the foundation
of the biotechnology, medical device, pharmaceutical and life science industries
in the state of Washington.
Tell us about Washington's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please e-mail: BioHistory@InfoResource.org
1848 -- American Association for the Advancement of Science founded.
American Association for the Advancement of Science founded in 1848
marked the emergence of a national scientific community in the United States, and was the first organization
established to promote the development of science and engineering at the national level and to represent the interests of
all its disciplines.
Today, the AAAS serves nearly 300 affiliated societies and academies of science and publishes the
peer-reviewed general science journal Science. The non-profit AAAS is open to all and fulfills its mission to "advance
science and serve society" through initiatives that include science policy, international programs, science education,
and public understanding of science.
1859 -- Charles Darwin published "The Origin of Species."
In 1859, British naturalist Charles Darwin published "On the Origin of Species by Means of
Natural Selection, or the Preservation of Favoured Races in the Struggle for Life"
in which he postulated his theory of evolution that explained how the diverse of
species on Earth evolved from a simple, singled-celled ancestor.
From 1831-1836, Darwin served as a naturalist aboard the H.M.S. Beagle -- a British
science expedition around the world. In South America Darwin discovered fossils of extinct animals
that were similar to modern species, and on the Galapagos Islands, located west of Equador,
he noticed many variations of plants and animals of the same general type as those in
South America. Throughout the expedition Darwin studied plants and animals
and collected specimens for further study.
Upon his return to London, Darwin conducted thorough research of his notes and specimens, and
out of his study grew several related theories: evolution did occur; evolutionary
change was gradual, requiring thousands to millions of years; the primary mechanism for
evolution was a process called natural selection; and the millions of species alive
today arose from a single original life form through a branching process called "specialization."
Darwin's theory of evolutionary selection holds that variation within species occurs randomly
and that the survival or extinction of each organism is determined by that organism's ability
to adapt to its environment. Darwin's theory of evolution remains the foundation of modern
biology.
Since 1969, the University of Washington (UW),
located in Seattle, has ranked among the top five institutions
in the nation in receipt of federal awards, and since 1974, it has been the number one
public university in America in receiving federal support for research and training.
The UW is the technology foundation of numerous biotechnology and medical device companies in
Washington State.
1865 -- Gregor Mendel, the father of modern genetics, presents his laws of heredity.
"In 1859 I obtained a very fertile
descendant with large, tasty seeds from a first generation hybrid. Since in the following
year, its progeny retained the desirable characteristics and were uniform, the variety was
cultivated in our vegetable garden, and many plants were raised every year up to
1865. (Gregor Mendel to Carl Nägeli, April 1867).
MendelWeb:
An educational resource for teachers and students.
1882 -- Benjamin P. Cheney Academy (Eastern Washington University) founded.
Eastern Washington University (EWU),
originally named Benjamin P. Cheney Academy for the wealthy transportation
industrialist who contributed $10,000 to found the school, is now a regional, comprehensive
public university located in Cheney with programs also offered in Bellevue, Everett, Kent,
Seattle, Shoreline, Spokane, Tacoma, Vancouver and Yakima. EWU has offered biotechnology courses
emphasizing on the job training since 1983, and has spun-off several biotechnolgy and medical
device companies based on EWU technology.
1890 -- Washington State University founded.
Washington State University (WSU), located in Pullman,
is one of the nation’s leading agricultural research
universities offering research programs in agriculture and veterinary medicine that have
received national recognition for work in bioenergetics, high yield wheat, and disease
control. WSU also offers extensive programs in biochemistry, molecular science, environmental
science and engineering, and wood materials engineering.
1887 -- Marine Hospital Service Hygienic Laboratory (National Institutes of Health) founded.
The National Institutes of Health (NIH) traces its roots to 1887,
when a one-room laboratory was created within the Marine Hospital Service (MHS), predecessor agency to the
U.S. Public Health Service (PHS). The MHS was established in 1798 to provide for the medical care of
merchant seamen -- charged by Congress with examining passengers on arriving ships for clinical signs of
infectious diseases, such as cholera and yellow fever, to prevent epidemics.
During the 1870s and 1880s, scientists in Europe presented compelling evidence that microscopic organisms
were the causes of several infectious diseases, and MHS officials closely followed these developments.
In 1887, Joseph Kinyoun, a MHS physician trained in the new bacteriological
methods, set up a one-room laboratory in the Marine Hospital at Stapleton, Staten Island,
New York. Kinyoun called this facility a "laboratory of hygiene" in imitation of German facilities, and within
a few months, he identified the cholera bacillus and used his Zeiss microscope to
demonstrate it to his colleagues as confirmation of their clinical diagnoses.
The Biologics Control Act enacted in 1902 had major consequences for the Hygienic Laboratory. It charged
the laboratory with regulating the production of vaccines and antitoxins, making it a regulatory agency
four years before passage of the 1906 Pure Food and Drugs Act. The danger posed by biological products that had
emerged from bacteriologic discoveries resulted from their production in animals and their administration by
injection. In 1901, thirteen children in St. Louis died after receiving diphtheria antitoxin contaminated
with tetanus spores. This tragedy spurred Congress to pass the Biologics Control Act, and between 1903-1907
standards were established and licenses issued to pharmaceutical firms for making smallpox and rabies vaccines,
diphtheria and tetanus antitoxins, and various other antibacterial antisera. (In 1972, responsibility
for regulation of biologics was transferred to the Food and Drug Administration).
(Photo: courtesy of the NIH Almanac)
In 1912 MHS was reorganized, renamed the Public Health Service (PHS)
and authorized to conduct research into noncontagious diseases and into the pollution of
streams and lakes in the U.S. During World War I, the PHS attended primarily to sanitation of areas
around military bases in the U.S., and when the 1918 influenza pandemic struck Washington, physicians from the
laboratory were pressed into service treating patients in the District of Columbia because so many local
doctors had fallen ill. In 1930, the Ransdell Act changed the name of the Hygienic Laboratory to the National Institute
of Health (NIH) and authorized the establishment of fellowships for research into basic biological and medical
problems. The roots of this act extended to 1918, when chemists who had worked with the Chemical Warfare
Service in World War I sought to establish an institute in the private sector to apply fundamental knowledge
in chemistry to problems of medicine. In 1937, the National
Cancer Institute (NCI) was created with sponsorship from every Senator in Congress, and was authorized
to award grants to nonfederal scientists for research on cancer and to fund fellowships at NCI for young
researchers.
During World War II, the NIH focused almost entirely on war-related problems. At the close of the war,
PHS leaders guided through Congress the 1944 Public Health Service Act, which defined the shape of medical
research in the post-war world. Two provisions were especially important: 1) In 1946 the NCI grants program was
expanded to the entire NIH, and the program grew from just over $4 million in 1947, to more than $100 million in
1957, and to $1 billion in 1974. The entire NIH budget expanded from $8 million in 1947 to more than $1 billion in
1966, now fondly remembered as "the golden years" of NIH expansion.
Accompanying growth in the grants program was the proliferation of new categorical institutes, and from
1946-1949, voluntary health organizations moved Congress to create institutes for research on mental health,
dental diseases, and heart disease. In 1948, language in the National Heart Act made the name of the
umbrella organization the National Institutes of Health. 2) The 1944 PHS Act authorized NIH to conduct clinical
research, and after the war Congress provided funding to build a research hospital, now called the Warren
Grant Magnuson Clinical Center on the NIH campus in Bethesda, Maryland. The Center which opened in 1953 with 540 beds
was designed to bring research laboratories into close proximity with hospital wards in order to promote
productive collaboration between laboratory scientists and clinicians.
(Photo: National Archives and Records Administration photograph, courtesy of the Franklin Delano
Roosevelt Library, Hyde Park, New York)
The NIH today, part of the U.S. Department of Health and Human Services, is the primary Federal agency
for conducting and supporting medical research and is composed of 27 Institutes and Centers, providing
leadership and financial support to researchers in every state and throughout the world.
1907 -- Children’s Orthopedic Hospital Association founded.
Children’s Orthopedic Hospital Association
now known as Children's Hospital and Regional Medical Center, was founded in 1907 when Anna Clise filed the articles of
incorporation for the new Hospital Association -- the first pediatric facility in the Northwest.
Anna Herr Clise, her husband James W. Clise and their newborn daughter Ruth arrived in Seattle
June 7, 1889, with the urging of James’ sister they left their home and prosperous real-estate business in Colorado
to join her in Seattle. James quickly became one of Seattle’s leading real-estate developers and financiers, and by
1893, Anna and James added two more children — both boys — to Seattle’s rapidly growing population of 43,000.
In 1898, tragedy struck the Clise family when their youngest son, 6-year-old Willis succumbed to an untreatable
inflammatory rheumatism (acute swelling of the body’s joints). At the time of Willis’ death, the closest
children’s hospital was in San Francisco; and the most advanced treatments for children was at Children’s Hospital
of Philadelphia. Out of this tragedy, Anna Herr Clise, with her family and other Seattle community leaders founded the
Children’s Orthopedic Hospital Association.
Today, Children's Hospital and Regional Medical Center occupies a 24-acre
site in Seattle's Laurelhurst neighborhood and serves as the pediatric referral center for Washington, Alaska, Montana and
Idaho. In 2006, the Seattle Children’s Hospital Research Institute was founded to “treat, prevent and eliminate childhood
disease”. The Research Institute campus encompasses two city blocks in Seattle's Denny Triangle Neighborhood, and occupies
two buildings totaling 500,000 square feet with adjacent land capable of supporting an additional 800,000 square feet.
The Seattle Children’s Hospital Research Institute is built around research centers with a common thematic focus
and an identifiable core set of programs. Each Center includes faculty from multiple disciplines, departments and divisions.
Research Centers include: Immunity & Vaccines, Translational & Clinical Science, Developmental Therapeutics, Childhood
Infections & Prematurity; Childhood Cancer; Tissue and Cell Biology; Genetics & Development; and Health Services &
Behavioral Science.
1918 -- Spanish Influenza Pandemic.
It is estimated that between 25 and 40 million people died
from the the influenza outbreak that began in 1918, swept across America in a week and
around the world in three months. In all, between 500,000 and 700,000 Americans
--civilians and soldiers-- died from the influenza, more than were lost in World War I,
II, and the Korean and Viet Nam wars combined.
The Spanish Flu reached the state of Washington in
September, 1918 with soldiers being transferred from Pennsylvania to Bremerton, returning
home from the battlefields of Europe in World War I. Across the state, public
assemblies were prohibited and citizens were required to wear gauze masks to prevent the
spread of the virus. By the end of September, it was estimated that 2,000 individuals had
died from the virus in Seattle. By 1920, the influenza outbreak was over, but given
the lack of statistical gathering, the true impact of the outbreak in the state will never
be known.
Latest Findings:
In September 2004, the National Institutes of Health (NIH) awarded a five-year,
$12.5 million grant to five institutions that will collaborate to study
genes constructed from 1918 flu-virus particles salvaged from the bodies of World
War I soldiers and the exhumed Brevig Mission, Alaska resident. The Institutions include
the Armed Forces Institute of Pathology, Washington, D.C.; Mount Sinai School of Medicine,
New York; Scripps Research Institute, La Jolla, CA; the Centers for Disease Control
and Prevention; and the University of Washington. The ultimate goal is to use knowledge
gained from the study to develop vaccines, influenza medications and diagnostic tests to
prevent a similar influenza outbreak.
Hollister-Stier Laboratories, located in Spokane,
is the oldest name in allergy science. The company was founded by
chemist Guy Hollister and Robert E. Stier, M.D., and began partially as the result of
Mrs. Hollister's "summer cold," which Hollister and Stier discovered was caused by
grasses in the area. The two friends developed a vaccine to help Mrs. Hollister, and the
company has been the leader in allergen extracts ever since.
1933 -- Thomas Hunt Morgan awarded Nobel Prize in Physiology or Medicine for his
chromosome theory of heredity.
Thomas Hunt Morgan pioneered the new science of genetics through experimental
research with the fruit fly (Drosophila), laying the foundations for the future of biology. On
the basis of fly-breeding experiments he demonstrated that genes are linked in a series on
chromosomes and that they determine indentifiable, hereditary traits.
1941-1983 -- Federal revenues flow into Washington State under
the political leadership of U.S. Senators Henry "Scoop" Jackson and Warren Magnuson.
Senators Henry "Scoop" Jackson and Warren G. Magnuson, nicknamed the "Gold Dust Twins" for
their ability to attract federal money, represented Washington in the U.S. Congress for
an ammassed total of eighty-nine years, and during that period their rise to seniority
leadership (a combined sixty-four years in the Senate) resulted in a growing stream of
federal dollars into Washington State. (Photos: Henry Jackson and Warren G. Magnuson
courtesy U.S. Senate Historical Office)
An influential Democrat in Washington State served in the Served in House of
Representatives from 1941-53 and the U.S. Senate from 1953-83.
Chair of the Democratic National Committee 1960.
Unsuccessful candidate for the democratic nomination for president in 1972 and 1976.
Jackson was influential on issues of particular interest to the West, including public
lands, reclamation, and hydroelectric power development.
Senator Jackson served as a member of the Interior and Energy Committee (Chair),
Joint Committee on Atomic Energy, Armed Services Committee, and Select Committee on
Intelligence.
Senator Jackson authored the landmark National Environmental Policy Act (NEPA),
Land Conservation Act of 1964, Wilderness Act of 1964, Wild and Scenic Rivers Act of
1968, established the Council on Environmental Quality (forerunner to the Environmental
Protection Agency, and sponsored legislation to preserve vast park lands and wilderness
areas throughout the U.S., including the North Cascades Park, Olympic National
Park, and the Alpine Lakes Wilderness Area in Washington State, and Redwood National Park
in Calfornia. He also authored the Alaska and Hawaii Statehood Acts.
An influential Democrat in Washington State served in the in the House of
Representatives from 1934-44 and U.S. Senate from 1944-81.
In 1937, Senator Magnuson introduced legislation creating the National Cancer Institute,
and in 1945 Magnuson introduced a bill to create a National Research Foundation
now known as the National Institutes of Health.
In the 1960's Senator Magnuson was instrumental in establishing the Medicare and
Medicaid programs, civil rights legislation and consumer protection legislation.
In 1970, Senator Magnuson introduced legislation establishing the National Oceanic
and Atmospheric Administration (NOAA), and is known as the "Father of NOAA."
In 1972, Senator Magnuson helped secure federal funds through the National Cancer
Institute to establish the Fred Hutchinson Cancer Research Center in Seattle now the leading
bone marrow transplant facility in the world.
In 1973, Senator Magnuson received the Albert Lasker Public Service Adward for his
outstanding leadership and support of medical research and health legislation for the
people of the United States.
The University of Washington’s health Science Center, established in 1970, is called
the Warren G. Manguson Health Sciences Center.
Senator Magnuson has been called one of the 20th century's most powerful legislators
West of the Mississippi next to his mentor Sam Rayburn and close friend Lyndon Johnson.
Magnuson's impact on the state of Washington continues to be felt ranging from
legislation and funding of hydroelectric dams (the foundation of the state's economy) and public
utility districts to the World's Fairs in Seattle and Spokane (including the Pacific Science
Center), the 200 mile foreign fishing limit, military bases, national parks and much more.
1947 -- Transistor invented at AT&T's Bell Laboratories.
The transistor, the invention that marked the dawn of the
information age, was invented by John Bardeen, William Shockley and Walter Brattain at AT&T's Bell Laboratories. Bardeen,
Shockley and Brattain were awarded the 1956
Nobel Prize in Physics for their discovery of the transistor effect.
Transistors have become an invisible technology that is
part of almost every electronic device. Every major information age innovation was made
possible by the transistor and its application can be found all around us.
The double helix structure of DNA, the hereditary molecule is revealed by
two scientists, James D. Watson and Francis Crick. This is one of the key
discoveries of the century. Watson and Crick shared the 1962
Nobel Prize for Physiology and Medicine with Maurice Wilkins for their discoveries
concerning the molecular structure of nuclear acids and its significance for information
transfer in living material.
1956 -- Pacific Northwest Research Foundation founded.
The Pacific Northwest Research Foundation (now Pacific
Northwest Research Institute) was founded by Dr. William Hutchinson. The Foundation was among
the first private non-profit biomedical and clinical research institutes in the Northwest.
It helped create and establish the Fred Hutchinson Cancer Research Center in 1972.
Today, PNRI conducts pioneering research into the mechanisms of disease. Its work in
cell biology, genetics, and immunology is focused on preventing and curing diabetes and cancer.
1956 -- Virginia Mason Research Center founded.
The Virginia Mason Research Center, now known as Benaroya Research Institute
at Virginia Mason (BRI), located in Seattle, is focused on molecular and cellular biology of the
human immune system and on genetics of human diseases. BRI has a clinical research program
that supports more than 150 studies each year, primarily Phase II-III medication and device
trials, in 25 different subspecialty areas.
1958 -- Integrated circuit invented.
Jack Kilby, an engineer at
Texas Instruments shows only a transistor and other components on a slice of
germanium. This invention (7/16-by-1/16-inches in size), called an integrated
circuit, revolutionized the electronics industry. Kilby was awarded
the 2000 Nobel Prize in
Physics for his invention of the integrated circuit.
(Photo: Jack Kilby courtesy of Texas Instruments)
1961 -- President John F. Kennedy expands U.S. Space Program
Listen to President John F. Kennedy's speech in
his historic message to a joint session of the Congress, on May 25, 1961 declared,
"...I believe this nation should commit itself to achieving the goal, before this decade
is out, of landing a man on the Moon and returning him safely to the Earth." This goal was
achieved when astronaut Neil A. Armstrong became the first human to set foot upon the
Moon at 10:56 p.m. EDT, July 20, 1969. Shown in the background are, (left) Vice
President Lyndon Johnson, and (right) Speaker of the House Sam T. Rayburn. The expansion of
the U.S. Space Program resulted in the development of a wide range of technology with
enormous benefit to human and animal kind.
(Photo: courtesy National Aeronautics & Space Administration)
Pacific Northwest National Laboratory, now known as Battelle
Pacific Northwest Division, was founded in 1965
when Battelle was awarded a contract to perform R&D for the Hanford Site, a nuclear site
in southeastern Washington State. Their core mission is to deliver environmental science
and technology in the service of the nation and humanity.
1969 -- Man walks on the moon.
In July of 1969, Neil Armstrong and Buzz Aldrin, American astronauts, made
history by becoming the first men to walk on the moon.
Listen to Neil Armstrong's first words as he steps onto the lunar
surface (66 kb .wav file).
(Photo: Courtesy of the National Aeronautics & Space Administration)
An important benefit of the Apollo Lunar Program and
other NASA programs is the ever-growing pipeline of technology that improves human and
veterinary healthcare diagnostics and therapeutics.
1969 -- Victor McKusick publishes "Mendelian Inheritance in Man".
Victor McKusick, widely acknowledged as the father of medical genetics, spent his career studying
the genetic basis of diseases and disorders with the belief that such an understanding could lead
to new methods of diagnosis and treatment. He studied, identified, and mapped genes responsible for
inherited conditions such as Marfan syndrome and dwarfism (specifically in Amish communities).
In 1969, he proposed the idea of mapping the human genome, over 30 years before the Human
Genome Project was established.
McKusick, a graduate of Johns Hopkins (M.D. 1946), spent his entire career there and founded
the Division of Medical Genetics in 1957, the first research center and clinic of its kind. In
1969 he published the 1st edition of his
book "Mendelian Inheritance of Man",
one of the most comprehensive collections of inherited disease genes. In 2002, McKusick received the
highest scientific honor in the U.S., the National Medal of Science.
1971 -- NASDAQ Stock Market founded.
Nasdaq, founded February 8, 1971, is now the largest U.S. electronic stock
market. With approximately 3,300 companies, it lists more companies and, on
average, trades more shares per day than any other U.S. market. NASDAQ is
home to companies that are leaders across all areas of business including
technology, retail, communications, financial services, transportation, media,
biotechnology, medical device, and pharmaceutical.
1972 -- Fred Hutchinson Cancer Research Center founded.
The "Hutch," one of 35 comprehensive cancer centers
nationwide, was established through the efforts of Dr. William Hutchinson, brother of
baseball hero Fred
Hutchinson, and Washington state's legendary U.S. Senator Warren Magnuson.
The Hutchinson Center and University of Washington are the
technology foundation of Washington's biotechnology industry. In fact, nearly
one-half of the biotechnology firms in the state are founded on technologies
developed at these institutions.
1973 -- Recombinant DNA perfected.
The modern era of biotechnology begins when Stanley Cohen of
Stanford University and Herbert Boyer of the University of
California at San Francisco successfully recombine ends of bacterial DNA after splicing a
toad gene in between. They call their accomplishment recombinant DNA,
but the media prefers using the term genetic engineering. (Photo: Courtesy Stanley Cohen)
1974 -- Employee Retirement Income Security Act of 1974 (ERISA).
John N. Erlenborn, the ranking Republican on the House Committee, was responsible for
bringing the Employee Retirement
Income Security Act of 1974 (ERISA) to a floor vote, and
is one of the ERISA’s "Founding Fathers." Together with Senator Jacob Javits (R-NY), Senator
Pete Williams (D-NJ) and Congressman John Dent (D-PA), Erlenborn crafted provisions and
participated in negotiations that were instrumental to the enactment of ERISA which was - and
remains - the single most important legislation governing employee benefit plans in the United
States providing an important source of financial investment for the stock market.
(Photos: Jacob Javits and Pete Williams courtesy U.S. Senate Historical Office).
1975 -- Monoclonal antibodies produced.
In 1975, Georges Köhler and César Milstein, showed how monoclonal antibodies can be generated by
isolating individual fused myeloma cells.
1976 -- Genentech, founder of the biotechnology industry, established.
Genentech was founded in 1976 by venture capitalist
Robert Swanson and biochemist Dr. Herbert Boyer. In the early 1970s, Boyer and
geneticist Stanley Cohen at Stanford University pioneered recombinant DNA technology.
Excited by the breakthrough, Swanson called Boyer who agreed to give the young entrepreneur
10 minutes of his time. Swanson's enthusiasm for the technology resulted in a three hour meeting
and at its conclusion, Genentech was born.
Within a few short years Swanson and Boyer invented a new industry - biotechnology.
In 1980, Genentech issued its Initial Public Offering (IPO) and raised $35 million
with an offering that jumped from $35 a share to a high of $88 after less than an hour on the
market. The event was one of the largest stock run-ups ever, and that event set the stage for
future biotechnolgy industry offerings.
Genentech was initially broadly focused in three areas including food processing,
industrial chemicals, and human health care. In 1982, Eli Lilly & Co. which had acquired
worldwide rights to Genenetch's recombinant human insulin (1978) received FDA approval to
market the product -- the first biotechnology therapeutic to reach the marketplace.
Beginning in 1983, Genentech became solely focused on human therapeutics
and diagnostics, and in 1985, Genentech received approval from FDA to market its first product,
Protropin® (somatrem for injection) growth hormone for children with growth hormone deficiency
— the first recombinant pharmaceutical product to be manufactured and marketed by a
biotechnology company. In 1990, Genentech and Roche Holding Ltd. of Basel, Switzerland completed a
$2.1 billion merger. Today, Genentech is among the world's leading biotech companies with
multiple protein-based products on the market for serious or life-threatening medical
conditions.
1980 -- U.S. Supreme Court ruled man-made organism patentable.
Diamond v. Chakrabarty, the U.S. Supreme Court upholds five-to-four the patentability of
genetically altered organisms, opening the door to greater patent protection for any
modified life forms.
In 1972, Chakrabarty, a microbiologist, filed a patent
application, assigned to the General Electric Co. for a human-made genetically engineered
bacterium capable of breaking down multiple components of crude oil. Because of this
property, which is possessed by no naturally occurring bacteria, Chakrabarty's invention
was believed to have significant value for the treatment of oil spills. The application
asserted 36 claims related to Chakrabarty's invention of "a bacterium from the genus
Pseudomonas containing therein at least two stable energy-generating plasmids, each of
said plasmids providing a separate hydrocarbon degradative pathway.
Opinions: Chief Justice Warren Burger delivered the opinion
of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and
John Paul Stevens joined. William Brennan filed a dissenting opinion, in which Byron
White, Thurgood Marshall, and Lewis Powell joined.
1980 -- Bayh-Dole Act provides for university technology transfer.
H.R.6933, Public Law: 96-517, December 12, 1980. A bill to amend title
35 of the United States Code. This Act known as the Bayh-Dole Act provided for the legal transfer of research and
technology originating from U.S. universities and federal laboratories to private
companies for commercialization. Technology transfer offices are now common in
universities and federal laboratories and are the technology foundation for numerous
biotechnology and medical device companies. (Photos: Birch Bayh and
Robert Dole courtesy U.S. Senate Historical Office)
Washington
Technology Transfer Resources -- A comprehensive listing of technology transfer
resources in the state of Washington, and select national and international resources.
1981 -- Immunex Corporation established.
Immunex Corporation, the largest biotechnology company in the Pacific Northwest,
was founded by Steven Gillis and Christopher Henney from the Fred Hutchinson Cancer Research Center, and Stephen Duzan.
It became publicly traded in 1983, and in 1991, with FDA approval of the drug Leukine, it became only the third fully integrated
pharmaceutical company to be created in the United States since 1945. Ultimately, Immunex became one of the S&P 500 and one of
the NASDAQ 100. The company was dedicated to developing immune system science to protect human health. The company was
acquired by Amgen in December 2001 for $16 billion in stock and net cash.
Duzan also played a role in the founding of Targeted Genetics Corporation, Corixa Corporation, and Spinal Dynamics
Corporation, all three of which became publicly traded or were sold to major corporations. Gillis co-founded
Corixa Corporation which became publicly traded and was was acquired by GlaxoSmithKline in July 2005. Christopher Henney
co-founded ICOS Corporation in 1992 which was sold to Eli Lilly in 2007. Henney also co founded Dendreon Corporation in
1992 which became publicly traded in 2000. (Photos: Steven Gillis, courtesy Corixa Corporation, and Christopher Henney courtesy of
Dendreon Corporation.)
1983 -- Orphan Drug Act created.
The Orphan Drug Act created in 1983
encouraged the research and development of drugs for rare or "orphan" diseases defined as a disease or condition that
affects fewer than 200,000 Americans.
The Orphan Drug Act provided for financial incentives to help companies recover the cost of developing much needed
therapies for small patient populations. The FDA estimates that more than 11 million patients in the U.S. and millions
more around the world, have benefited from this legislation.
1983 -- Washington Technology Center founded.
The Washington Technology Center (WTC), located in Seattle, was founded in 1983 by the Washington
Legislature as a statewide economic agency under the Washington High Technology and
Training Act. The WTC focuses on technology and innovation, and channels state, federal,
and private resources to help companies develop and commercialize new products and
technologies.
1986 - Microsoft Corporation Initial Public Offering.
Microsoft Corporation, founded
by Bill Gates Jr. and Paul Allen in 1975, and headquartered in
Redmond, Washington, has had a significant impact on the Seattle and
Washington State economy. The state's biotechnology industry, in particular, has
been a major beneficiary of Gates, Allen and other Microsoft employee investments.
1989 -- Washington State Legislature creates Governor's Biotechnology Advisory Committee.
The Biotechnology Targeted Sector legislation required the advisory committee, composed of private and public leaders of the state's
biotechnology and medical device industries, to assess the status of the biotechnology industry in the Washington State, and to
develop a program with the Department of Trade and Economic Development (DTED) to increase biotechnology employment, capital investment and
product sales, and develop an evaluation process to measure the program's effectiveness.
Committee recomendations included improving the state's tax structure to encourage company development, supporting investment
in higher education and hands-on training programs, the creation of a state-supported biotechnology investment fund, and the creation of
incubator facilities and shared equipment programs. To support the implementation of the committee's recommendations, DTED assisted in the
founding of the Washington Biotechnology & Biomedical Association (WBBA) in 1989. In 1990, the WBBA initiated dialogue with the
State's Legislature resulting in the inital paassage in 1994 of Washington State Sales Tax Exemption for High
Technology R&D/Manufacturing. This initial tax legislation was subsequently expanded and modified to further support the state's
industry.
1989 -- Washington Biotechnology & Biomedical Association founded.
The Washington Biotechnology & Biomedical Association (WBBA)
is a non-profit trade organization founded to enhance the quality of
life by promoting the growth and understanding of the biotechnology and medical technology
industries within Washington State.
1990 -- ICOS Corporation established.
ICOS Corporation, acquired by Eli Lilly and Co. in 2006 for $2.1 billion, was
founded by Robert Nowinski, Christopher Henney and George Rathmann. The company was focused
on discovering, developing and commercializing treatments
for inflammation and other serious diseases. ICOS was established with $33 million in
private financing, the largest industry start-up financing to date, with Microsoft
co-founder Bill Gates as the largest shareholder. ICOS made its initial public
offering in 1991 at $8.00 per share. (Photos: Christopher Henney courtesy of Dendreon Corporation,
and George Rathmann, courtesy ICOS Corporation)
1990 -- E. Donnall Thomas, awarded Nobel Laureate in Medicine.
E. Donnall Thomas from the
Fred Hutchinson Cancer Research Center was awarded the 1990 Nobel Prize for
Medicine for discoveries concerning organ and cell transplantation in the treatment of
human disease. (Photo: E. Donnall Thomas, courtesy Fred Hutchinson Cancer Research Center)
1990 -- Human Genome Project established.
The U.S. Human Genome
Project was established -- a 13-year effort coordinated by the U.S.
Department of Energy and the National Institutes of Health. The project, originally
planned to last 15 years, was expected to be completed by 2003 due to
rapid technological advances.
Project Goals
Identify all the estimated 80,000 genes in human DNA,
Determine the sequences of the 3 billion chemical bases that make up human DNA,
Store this information in databases,
Develop tools for data analysis, and
Address the ethical, legal, and social issues that may arise from the project.
1991 -- Leroy Hood recruited to University of Washington.
The University of Washington's medical school announced a $12
million gift from Microsoft co-founder and chairman Bill Gates that allowed Leroy Hood to
be recruited to Seattle from Caltech. Dr. Hood, best known for his work developing
automatic gene sequencing machines, becomes Chair of the UW's Department of Molecular
Biotechnology. (Photo: Leroy Hood, courtesy Institute for Systems Biology)
1993 -- Biotechnology Industry Organization (BIO) founded.
Biotechnology Industry
Organization is the world's largest organization to serve and represent the
biotechnology industry. BIO's leadership and service-oriented guidance have helped advance
the industry and bring the benefits of biotechnology to people everywhere.
1993 -- Kary B. Mullis awarded Nobel Prize in Chemistry.
PCR allows scientists to quickly replicate small strands of DNA, greatly simplifying
the sequencing and cloning of genes. First presented in 1985, PCR has become one of
the most widespread methods of analyzing DNA. Notably, PCR requires the heat-stable enzyme
Taq (Thermus Aquaticus) which originated from hot springs located in Yellowstone
National Park.
1994 -- Spokane Intercollegiate Research & Technology Institute founded.
Spokane Intercollegiate Research & Technology Institute (SIRTI),
located in Spokane, was founded by the Washington Legislature as a State
agency with a mission to accelerate the development and growth of
technology companies in Eastern Washington. SIRTI works with three types
of clients: university technology transfer, start-ups and more
established, but still emerging ("high growth") companies. SIRTI
provides a range of services: business planning market evaluation,
product development advice, financial modeling, technology and
intellectual property assessment, provision of business and technology
mentors, access to financial resources (largely debt finance) and grant
assistance. SIRTI also operates two incubators, one in its long-standing
mixed use building on the Spokane Riverpoint campus and a new, wet lab
oriented technology center at another site on the campus.
1994 -- WA State Sales Tax Exemption for High Technology R&D/Manufacturing enacted.
The Sales Tax Exemption for High Technology R&D/Manufacturing enacted into law by the Washington
State Legislature in 1994 (Engrossed Substitute Senate Bill 5201, now enacted as Revised
Code of Washington 82.63). This law exempts companies that manufacture or who are
engaged in research and development from paying the sales or use tax on machinery and
equipment used directly in manufacturing or research operations.
This tax incentive, sponsored by Rep. Bill Finkbeiner, was
the result of many years of work by numerous individuals from the private sector, the
Department of Trade and Economic Development, the Legislature, the Governor's office and
the Department of Revenue. In the end, the legislation received bipartisan support in the
House (78 yes; 15 no; 5 absent) and in the Senate (34 yes; 11 no; 4 absent).
Rep. Bill Finkbeiner, Sen. Sylvia Skratek, Rep. Jim Johansen, Tom Ranken (Immunex), Pat Dunn, Howard Mendelsohn (ICOS), Phil Ness (DTED), Vickie Chiechi with Governor Mike Lowry, April 4, 1994 -- Signing High Technology Tax Incentive Bill.
1999 -- BIO'99 International Meeting & Exhibition held in Seattle.
The BIO International Meeting & Exhibition is World's premier biotechnology
meeting. The BIO'99 event was hosted by the Washington Biotechnology & Biomedical
Association and the Biotechnology Industry Organization
at the Washington State Convention Center in Seattle.
2000 -- Institute for Systems Biology founded.
Institute for Systems Biology (ISB),
located in Seattle, was founded in 2002 by Alan Aderem, Ruedi Aebersold, and Leroy Hood,
as a non-profit research institute dedicated to the study and application of systems biology.
ISB's goal is to unravel the mysteries of human biology to identify strategies for predicting
and preventing diseases such as cancer, arthritis and AIDS.
2001 -- Human Genome Project draft sequence published.
The February 16 issue of Science and February
15 issue of Nature contained the working draft of the human genome
sequence (U.S. Human Genome
Project). Nature papers included initial analysis of the descriptions of the sequence
generated by the publicly sponsored Human Genome Project, while Science publications focused
on the draft sequence reported by the private company, Celera Genomics.
2001 -- Leland H. Hartwell, awarded Nobel Laureate in Medicine.
Leland H.Hartwell from the Fred Hutchinson Cancer Research
Center was awarded the 2001
Nobel Prize for Medicine for discoveries of key regulators of the cell cycle.
(Photo: Leland Hartwell, courtesy Fred Hutchinson Cancer Research
Center)
2002 -- Immunex Corporation acquired by Amgen.
On July 15, 2002, Amgen (Nasdaq: AMGN) completed it's acquisition of Immunex Corporation
for $16 billion in stock and net cash.
2003 -- The Allen Brain Atlas established.
The Allen Brain Atlas project, was established with
$100 million and named for its founder Paul G. Allen. The project will combine the
disciplines of neuroanatomy and genomics to create the most
comprehensive map of the brain at the cellular level, illustrating the functional anatomy of the
brain through a collection of gene expression maps, brain circuits and cell locations.
The Allen Brain Atlas will be the cornerstone of 21st century brain science. Researchers around
the world will leverage information from the Brain Atlas to gain insights into some of the
most profound and challenging questions facing science in this century.
2004 -- Linda Buck awarded Nobel Laureate in Medicine.
Linda B. Buck from the Fred Hutchinson Cancer Research
Center was awarded the 2004
Nobel Prize for Medicine for discoveries of odorant receptors and the organization of the olfactory system.
(Photo: Linda Buck, courtesy Fred Hutchinson Cancer Research Center)
2005 -- Life Sciences Discovery Fund Authority established.
Life Sciences
Discovery Fund Authority was created in 2005 as an agency of the
state and governed by a board of trustees. The Authority was established as an
account in the State Treasury and a total of $350 million in forthcoming tobacco
settlement funds will be used to attract an additional $650
million in private capital. The $1 billion fund will be used to help finance
groundbreaking research and development of biomedical and other scientific advances
to ease human suffering and make Washington a center for these activities.
2008 -- WA BioEvolution illustrates the technology origins of state's industry.
WA BioEvolution -- a one-of-a-kind
genealogy chart that illustrates the "technology origins" of more than 250 firms and
non-profit research organizations that comprise the biotechnology and medical device
industry in the state of Washington.
Other Resources
WA BioEvolution Genealogy Poster --
A one-of-a-kind genealogy poster that illustrates the "technology origins" of the
more than 250 firms and non-profit research organizations that comprise the biotechnology
and medical device industry in the state of Washington
ZymoGenetics Steam Plant --
Tour the ZymoGenetics historic landmark Hydro House and Steam Plant located on Lake Union in
Seattle. A photographic collection from the driving of the first pilings in 1914 to its
renovation into a modern biotechnology research facility.
Suggested
Science Education Reading -- A list of select biotechnology and other science related books to help you understand the world of biotechnology.
Suggested CEO Reading
-- A list of select books recommended by some of the nation's leading chief
executive officers from the biotechnology, medical technology and related industry.
Tell us about Washington's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please e-mail: BioHistory@InfoResource.org